American Infusion Services is a health care startup founded in 2021 and headquartered in the United States. The company's slogan "Fight COVID with mAbs" emphasizes its focus on offering Monoclonal Antibody Treatment for COVID-19, both at home and for long-term care facilities. The startup provides a new monoclonal antibody therapy (mAb) for individuals who have been exposed or tested positive for COVID-19. This therapy aims to protect against infection, hospitalization, and worsening disease, with a 70%-85% reduction in hospitalization and death among patients and an 80% reduction of infection among patients' households. The treatment, administered either intravenously or through injections, is offered free for qualifying individuals. The company's innovative approach and timely solution to addressing the challenges of COVID-19 make it a promising investment opportunity in the health care industry.
There is no investment information
No recent news or press coverage available for American Infusion Services.